By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company InMode Ltd.

InMode Ltd. (INMD)

NASDAQ Currency in USD
$496.00
-$0.42
-0.09%
Last Update: 18 Jul 2026, 14:11
$32.06bn
Market Cap
364.71
P/E Ratio (TTM)
Forward Dividend Yield
$353.83-$598.34
52 Week Range

INMD Stock Price Chart

Explore InMode Ltd. interactive price chart. Choose custom timeframes to analyze INMD price movements and trends.

INMD Company Profile

Discover essential business fundamentals and corporate details for InMode Ltd. (INMD) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

8 Aug 2019

Employees

599.00

CEO

Moshe Mizrahy

Description

InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.

INMD Financial Timeline

Browse a chronological timeline of InMode Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 23 Jul 2026

EPS estimate is $0.33, while revenue estimate is $93.04m.

Earnings released on 6 May 2026

EPS came in at $0.25 falling short of the estimated $0.30 by -16.05%, while revenue for the quarter reached $82.02m , beating expectations by +2.72%.

Earnings released on 10 Feb 2026

EPS came in at $0.46 surpassing the estimated $0.42 by +10.52%, while revenue for the quarter reached $103.85m , beating expectations by +2.33%.

Earnings released on 5 Nov 2025

EPS came in at $0.38 surpassing the estimated $0.35 by +8.32%, while revenue for the quarter reached $93.17m , beating expectations by +2.45%.

Earnings released on 30 Jul 2025

EPS came in at $0.47 surpassing the estimated $0.43 by +9.30%, while revenue for the quarter reached $95.60m , missing expectations by -2.89%.

Earnings released on 28 Apr 2025

EPS came in at $0.31 falling short of the estimated $0.33 by -6.06%, while revenue for the quarter reached $77.87m , missing expectations by -20.90%.

Earnings released on 4 Feb 2025

EPS came in at $0.42 falling short of the estimated $0.50 by -16.00%, while revenue for the quarter reached $97.85m , missing expectations by -6.81%.

Earnings released on 30 Oct 2024

EPS came in at $0.70 surpassing the estimated $0.63 by +11.11%, while revenue for the quarter reached $130.23m , beating expectations by +13.46%.

Earnings released on 1 Aug 2024

EPS came in at $0.34 falling short of the estimated $0.38 by -10.53%, while revenue for the quarter reached $86.45m , missing expectations by -14.97%.

Earnings released on 2 May 2024

EPS came in at $0.32 falling short of the estimated $0.41 by -21.95%, while revenue for the quarter reached $80.28m , missing expectations by -10.28%.

Earnings released on 13 Feb 2024

EPS came in at $0.71 surpassing the estimated $0.67 by +5.97%, while revenue for the quarter reached $126.78m , beating expectations by +1.39%.

Earnings released on 2 Nov 2023

EPS came in at $0.61 falling short of the estimated $0.64 by -4.69%, while revenue for the quarter reached $123.11m , missing expectations by -6.92%.

Earnings released on 27 Jul 2023

EPS came in at $0.72 surpassing the estimated $0.64 by +12.50%, while revenue for the quarter reached $136.08m , beating expectations by +3.09%.

Earnings released on 2 May 2023

EPS came in at $0.52 surpassing the estimated $0.47 by +10.64%, while revenue for the quarter reached $106.07m , beating expectations by +4.72%.

Earnings released on 14 Feb 2023

EPS came in at $0.78 surpassing the estimated $0.74 by +5.41%, while revenue for the quarter reached $133.57m , beating expectations by +2.99%.

Earnings released on 27 Oct 2022

EPS came in at $0.66 surpassing the estimated $0.58 by +13.79%, while revenue for the quarter reached $121.23m , beating expectations by +6.79%.

Earnings released on 28 Jul 2022

EPS came in at $0.59 surpassing the estimated $0.51 by +15.69%, while revenue for the quarter reached $113.55m , beating expectations by +10.08%.

Earnings released on 2 May 2022

EPS came in at $0.40 surpassing the estimated $0.38 by +5.26%, while revenue for the quarter reached $85.92m , beating expectations by +7.10%.

Earnings released on 10 Feb 2022

EPS came in at $0.64 surpassing the estimated $0.56 by +14.29%, while revenue for the quarter reached $110.54m , beating expectations by +5.29%.

Earnings released on 26 Oct 2021

EPS came in at $0.55 surpassing the estimated $0.50 by +10.00%, while revenue for the quarter reached $94.18m , beating expectations by +27.16%.

Stock split effective on 1 Oct 2021

Shares were split 2 : 1 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 28 Jul 2021

EPS came in at $0.51 surpassing the estimated $0.43 by +18.60%, while revenue for the quarter reached $87.33m , beating expectations by +17.91%.

INMD Stock Performance

Access detailed INMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run